Cencora
Sandy Yu is a seasoned financial professional with extensive experience in financial analysis and planning. Currently serving as a Senior Financial Analyst in FP&A at AmerisourceBergen since July 2021, Sandy has a track record of enhancing financial operations across various industries, including retail, construction, auto repair technology, and entertainment, through roles at Robert Half and Caliber Collision Centers. Prior experiences as a Financial Analyst at iHeartMedia and Cashmax Title & Loan involved streamlining operations and conducting budget analyses. Early career positions included internships focusing on financial modeling, reporting, and audits at Flexi Compras and ECOM Trading. Sandy holds a Master of Science in Finance from The University of Texas at Dallas and a Bachelor of Science in Finance and Banking from National Chengchi University.
This person is not in any teams
This person is not in any offices
Cencora
45 followers
Cencora, a company building on the legacy of AmerisourceBergen, is a leading global pharmaceutical solutions organization centered on improving the lives of people and animals around the world. We connect manufacturers, providers, and patients to ensure that anyone can get the therapies they need, where and when they need them. We also help our partners bring their innovations to patients more efficiently to accelerate positive outcomes. Becoming Cencora has allowed us to combine all the companies and services of AmerisourceBergen. Now, as a unified and internationally inclusive brand, we’re continuing to invest in and focus on our core pharmaceutical distribution business, while also growing our platform of pharma and biopharma services to support pharmaceutical innovation and access. Our 46,000+ worldwide team members are shaping the future of healthcare through the power of our purpose: We are united in our responsibility to create healthier futures. AmerisourceBergen, now Cencora, is ranked #10 on the Fortune 500 and #24 on the Global Fortune 500 with more than $230 billion in annual revenue.